Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Novel function of CD81 in controlling hepatitis C virus replication.

Zhang YY, Zhang BH, Ishii K, Liang TJ.

J Virol. 2010 Apr;84(7):3396-407. doi: 10.1128/JVI.02391-09.

2.

Active RNA replication of hepatitis C virus downregulates CD81 expression.

Ke PY, Chen SS.

PLoS One. 2013;8(1):e54866. doi: 10.1371/journal.pone.0054866.

3.

The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles.

Morikawa K, Zhao Z, Date T, Miyamoto M, Murayama A, Akazawa D, Tanabe J, Sone S, Wakita T.

J Med Virol. 2007 Jun;79(6):714-23.

PMID:
17457918
4.

Superinfection exclusion in cells infected with hepatitis C virus.

Tscherne DM, Evans MJ, von Hahn T, Jones CT, Stamataki Z, McKeating JA, Lindenbach BD, Rice CM.

J Virol. 2007 Apr;81(8):3693-703.

5.

Hepatitis C virus entry and the tetraspanin CD81.

Farquhar MJ, Harris HJ, McKeating JA.

Biochem Soc Trans. 2011 Apr;39(2):532-6. doi: 10.1042/BST0390532. Review.

PMID:
21428934
6.

The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells.

Koutsoudakis G, Herrmann E, Kallis S, Bartenschlager R, Pietschmann T.

J Virol. 2007 Jan;81(2):588-98.

7.

CD81 is an entry coreceptor for hepatitis C virus.

Cormier EG, Tsamis F, Kajumo F, Durso RJ, Gardner JP, Dragic T.

Proc Natl Acad Sci U S A. 2004 May 11;101(19):7270-4.

8.

Two methods of heterokaryon formation to discover HCV restriction factors.

Frentzen A, Hueging K, Bitzegeio J, Pietschmann T, Steinmann E.

J Vis Exp. 2012 Jul 16;(65):e4029. doi: 10.3791/4029.

9.

Complete replication of hepatitis C virus in cell culture.

Lindenbach BD, Evans MJ, Syder AJ, Wölk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM.

Science. 2005 Jul 22;309(5734):623-6.

10.

Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection.

Zhao X, Tang ZY, Klumpp B, Wolff-Vorbeck G, Barth H, Levy S, von Weizsäcker F, Blum HE, Baumert TF.

J Clin Invest. 2002 Jan;109(2):221-32.

11.

CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells.

Witteveldt J, Evans MJ, Bitzegeio J, Koutsoudakis G, Owsianka AM, Angus AG, Keck ZY, Foung SK, Pietschmann T, Rice CM, Patel AH.

J Gen Virol. 2009 Jan;90(Pt 1):48-58. doi: 10.1099/vir.0.006700-0.

12.

Diverse CD81 proteins support hepatitis C virus infection.

Flint M, von Hahn T, Zhang J, Farquhar M, Jones CT, Balfe P, Rice CM, McKeating JA.

J Virol. 2006 Nov;80(22):11331-42.

13.

Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.

Tong Y, Zhu Y, Xia X, Liu Y, Feng Y, Hua X, Chen Z, Ding H, Gao L, Wang Y, Feitelson MA, Zhao P, Qi ZT.

J Virol. 2011 Mar;85(6):2793-802. doi: 10.1128/JVI.01818-10.

14.

Two conserved histidines (His490 and His621) on the E2 glycoprotein of hepatitis C virus are critical for CD81-mediated cell entry.

Qin ZL, Ju HP, Gao TT, Wang WB, Ren H, Zhao P, Qi ZT.

J Gen Virol. 2015 Jun;96(Pt 6):1389-99. doi: 10.1099/vir.0.000091.

PMID:
25701820
15.

Trans-encapsidation of hepatitis C virus subgenomic replicon RNA with viral structure proteins.

Ishii K, Murakami K, Hmwe SS, Zhang B, Li J, Shirakura M, Morikawa K, Suzuki R, Miyamura T, Wakita T, Suzuki T.

Biochem Biophys Res Commun. 2008 Jul 4;371(3):446-50. doi: 10.1016/j.bbrc.2008.04.110.

PMID:
18445476
16.

Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner.

McKeating JA, Zhang LQ, Logvinoff C, Flint M, Zhang J, Yu J, Butera D, Ho DD, Dustin LB, Rice CM, Balfe P.

J Virol. 2004 Aug;78(16):8496-505.

17.

Identification of transferrin receptor 1 as a hepatitis C virus entry factor.

Martin DN, Uprichard SL.

Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):10777-82. doi: 10.1073/pnas.1301764110.

18.

CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry.

Harris HJ, Farquhar MJ, Mee CJ, Davis C, Reynolds GM, Jennings A, Hu K, Yuan F, Deng H, Hubscher SG, Han JH, Balfe P, McKeating JA.

J Virol. 2008 May;82(10):5007-20. doi: 10.1128/JVI.02286-07.

19.

Hepatitis C virus infection of neuroepithelioma cell lines.

Fletcher NF, Yang JP, Farquhar MJ, Hu K, Davis C, He Q, Dowd K, Ray SC, Krieger SE, Neyts J, Baumert TF, Balfe P, McKeating JA, Wong-Staal F.

Gastroenterology. 2010 Oct;139(4):1365-74. doi: 10.1053/j.gastro.2010.06.008.

20.

Bile acids specifically increase hepatitis C virus RNA-replication.

Chhatwal P, Bankwitz D, Gentzsch J, Frentzen A, Schult P, Lohmann V, Pietschmann T.

PLoS One. 2012;7(4):e36029. doi: 10.1371/journal.pone.0036029.

Items per page

Supplemental Content

Support Center